PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
05-Dec-2023 MM Packaging set to take centre stage at Pharmapack Europe 2024 MM Packaging
05-Dec-2023 KBI Biopharma, Inc. Appoints Maggie Chen as Site Head of Patriot Park Mammalian cGMP Manufacturing Facility KBI Biopharma
05-Dec-2023 Vetter Joins Science Based Targets Initiative (SBTi) B3C newswire
05-Dec-2023 Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers Mainz BioMed N.V.
05-Dec-2023 Gerresheimer AG: Guido Pickert to head up Investor Relations at Gerresheimer Gerresheimer AG
05-Dec-2023 Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board Thermosome GmbH
05-Dec-2023 Formycon announces participation in international Investor Conferences in Q1/2024 Formycon AG
05-Dec-2023 Spexis is Granted Debt-Restructuring Moratorium Spexis AG
05-Dec-2023 Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth Relief Therapeutics Holding SA
04-Dec-2023 Aqilion appoints Gustaf Albèrt as new CFO Aqilion
04-Dec-2023 UCB announces European Commission approval of ZILBRYSQ®▼ (zilucoplan) for the treatment of adults with generalized Myasthenia Gravis UCB
04-Dec-2023 Boyds grows regulatory affairs team with new hire Boyds
04-Dec-2023 CNX Therapeutics to expand CNS portfolio through the acquisition of two established brands from Sanofi CNX Therapeutics
04-Dec-2023 EBViously Presents Novel In-Vitro Data Demonstrating Potent Infection Prevention of its Vaccine Candidate EBV-001 EBViously GmbH
04-Dec-2023 Discovery Park Ventures expands fund to £3m to invest in more innovative science and technology start-ups Sciad Newswire
30-Nov-2023 HAEMATO AG: Termination of listing in the Open Market HAEMATO AG
30-Nov-2023 Formycon and Fresenius Kabi announce File Acceptance for FYB202, a biosimilar candidate to Stelara® (ustekinumab), by the U.S. Food and Drug Administration Formycon AG
30-Nov-2023 Evolva convenes extraordinary general meeting (EGM) for 21 December 2023 to approve the sale of Evolva AG to Lallemand Inc. Evolva Holding SA
29-Nov-2023 Qnovia, Inc. announces positive results from first-in-human pharmacokinetic and safety study of lead asset QN-01, a prescription inhaled smoking cessation therapy Qnovia
29-Nov-2023 Medacta further expands in Rancate, Switzerland, doubling its production capability to support the future growth Medacta Group SA